Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹109 Cr₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹109 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹109 Cr
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹109 Cr
Positive
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,325.9 Cr 4.9% 6% 63.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.9%

6%

63.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses